These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36553917)

  • 1. Effect of Didactic Training on Barriers and Biases to Treatment of Opioid Use Disorder: Meeting the Ongoing Needs of Patients with Opioid Use Disorder in the Emergency Department during the COVID-19 Pandemic.
    Johnson E; Bolshakova M; Vosooghi A; Lam CN; Trotzky-Sirr R; Bluthenthal R; Schneberk T
    Healthcare (Basel); 2022 Nov; 10(12):. PubMed ID: 36553917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Implementation of a Curriculum for Emergency Medicine Residents to Address Medications and Treatment Referral for Opioid Use Disorder.
    Walter LA; Hess J; Brown M; DeLaney M; Paddock C; Hess EP
    Subst Use Misuse; 2021; 56(4):458-463. PubMed ID: 33587018
    [No Abstract]   [Full Text] [Related]  

  • 3. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.
    Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D
    Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656
    [No Abstract]   [Full Text] [Related]  

  • 4. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
    Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
    Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician-Perceived Barriers to Treating Opioid Use Disorder in the Emergency Department.
    Logan G; Mirajkar A; Houck J; Rivera-Alvarez F; Drone E; Patel P; Craen A; Dub L; Elahi N; Lebowitz D; Walker A; Ganti L
    Cureus; 2021 Nov; 13(11):e19923. PubMed ID: 34966614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder.
    Robles M; Mortazavi L; Vannerson J; Matthias MS
    Teach Learn Med; 2022; 34(5):514-521. PubMed ID: 33974460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and guide for embedding opioid use disorder education in health professions' curricula.
    Salvador JG; Bolaños-Sacoman SL; Katzman JG; Morrison AE; Fox LE; Schneider JS; Bhatt SR; Kincaid TW; Waldorf VA
    BMC Med Educ; 2023 Mar; 23(1):135. PubMed ID: 36859298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Resident Physicians' Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder.
    Shuey B; Lee D; Ugalde I; Borgan S; Bresnan C; Qureshi M; Mhaskar R; Oxner A
    J Addict Med; 2021 May-Jun 01; 15(3):219-225. PubMed ID: 33079729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department.
    Wiercigroch D; Hoyeck P; Sheikh H; Hulme J
    BMC Emerg Med; 2021 Apr; 21(1):48. PubMed ID: 33858328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors.
    Windish DM; Catalanotti JS; Zaas A; Kisielewski M; Moriarty JP
    J Gen Intern Med; 2022 Aug; 37(11):2650-2660. PubMed ID: 34729698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing North Carolina's Workforce Capacity for Prescribing Buprenorphine Products.
    Cabello-De la Garza A; Harless C; Ostrach B; Fagan B
    N C Med J; 2022; 83(4):288-293. PubMed ID: 35817448
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.
    Gregory HM; Hill VM; Parker RW
    Cureus; 2021 Nov; 13(11):e19870. PubMed ID: 34976492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Treatments for Opioid Use Disorder.
    Fairley M; Humphreys K; Joyce VR; Bounthavong M; Trafton J; Combs A; Oliva EM; Goldhaber-Fiebert JD; Asch SM; Brandeau ML; Owens DK
    JAMA Psychiatry; 2021 Jul; 78(7):767-777. PubMed ID: 33787832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of medication-assisted treatment for opioid use disorder.
    Ghanem N; Dromgoole D; Hussein A; Jermyn RT
    J Osteopath Med; 2022 Mar; 122(7):367-374. PubMed ID: 35285220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Ability to Treat Opioid Use Disorder in West Virginia.
    Sheppard AB; Young JC; Davis SM; Moran GE
    J Appalach Health; 2021; 3(2):32-42. PubMed ID: 35769171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid stewardship training during the transition to residency to prepare medical students to recognize and treat opioid use disorder.
    Estave PM; Jacobs ML; Rukstalis M; Goforth J; Stone SN; Choi JA; Barrett J; Douglas HE; Oliver JB; Keating MK; Freischlag JA; O'Brien MC; McEwen S; Strowd RE
    Subst Abus; 2021; 42(4):1040-1048. PubMed ID: 34236292
    [No Abstract]   [Full Text] [Related]  

  • 17. Resident attitudes, experiences, and preferences on initiating buprenorphine in the emergency department: A national survey.
    Yu MJ; Hawk K
    AEM Educ Train; 2022 Jun; 6(3):e10779. PubMed ID: 35784380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
    Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
    J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD).
    Khatri UG; Lee K; Lin T; D'Orazio JL; Patel MS; Shofer FS; Perrone J
    J Med Toxicol; 2022 Jul; 18(3):205-213. PubMed ID: 35415804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
    Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
    Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.